Senior insider sale
XENON PHARMACEUTICALS INC. — senior position signals high conviction
$754.2K
18.98K shares
What this filing means
PATOU GARY plans to sell 18.98K shares of XENON PHARMACEUTICALS INC. valued at approximately $754.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/14/2023ACC: 0001959173-23-005475
18.98K
Shares to sell
$754.2K
Approx. market value
7.60K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Open Market Buy
Cash/Check
8/10/2017
7.50KOpen Market Buy
Cash/Check
8/8/2017
98.00Total acquired7.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/10/2017 | Open Market Buy Cash/Check | 7.50K | — |
8/8/2017 | Open Market Buy Cash/Check | 98.00 | — |
| Total | 7.60K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
11.38K
Market value
$447.1K
12/13/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.60K
Market value
$307.1K
12/14/2023
Total
Units
18.98K
Value
$754.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/13/2023 | 11.38K | $447.1K | — | Completed |
| Planned — Approximate Date | ||||
12/14/2023 | 7.60K | $307.1K | NASDAQ | Planned |
| Total | 18.98K | $754.2K | ||